Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes.
about
Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1Hemoglobin is a co-factor of human trypanosome lytic factorA single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 bindingHaptoglobin binds the antiatherogenic protein apolipoprotein E - impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytesHydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomesShotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLDistinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serumImmune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to PathogenicityDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsProteomics investigations of HDL: challenges and promiseTrypanosome resistance to human innate immunity: targeting Achilles' heelSequence conservation of apolipoprotein A-I affords novel insights into HDL structure-functionStructural basis for trypanosomal haem acquisition and susceptibility to the host innate immune systemSelf/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties.The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptidesMD simulations suggest important surface differences between reconstituted and circulating spherical HDL.Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection.Evolution of the primate trypanolytic factor APOL1Immunobiology of African trypanosomes: need of alternative interventionsProteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality.Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor.A retained secretory signal peptide mediates high density lipoprotein (HDL) assembly and function of haptoglobin-related protein.In vitro generation of human high-density-lipoprotein-resistant Trypanosoma brucei bruceiThe TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense.Antimicrobial peptide killing of African trypanosomes.Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei bruceiHuman apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.Individual variation in levels of haptoglobin-related protein in children from GabonA comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteinsTrypanosome Lytic Factor-1 Initiates Oxidation-stimulated Osmotic Lysis of Trypanosoma brucei brucei.Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model.Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid.Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complexProteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyondVolumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies.The HDL proteome: a marker--and perhaps mediator--of coronary artery disease.Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies.
P2860
Q21092282-30696303-E5BC-4537-9797-550AB4161D9EQ21131604-FD229562-8342-4EF0-AF62-2D433EE7EB63Q21558778-8B1BB629-A4B3-4FD4-BA17-39F3A9854AD8Q24316403-ECB9A48A-C66C-4358-ABBA-4F218E9BB8B4Q24652930-CA434569-0358-4454-83C1-4C725BFD61EEQ24669594-9D983CEB-F70E-426D-B979-02E3C3F6CD2FQ24681132-B408357D-24F3-4448-8F63-69DC34A18A2AQ26742172-A2F15BAF-85FC-42B5-842F-DB9C900FF616Q26774903-55A5ABB5-C7A8-4FCE-88A3-A165F5909D53Q27000995-3CFC0622-1A98-46BA-AE7C-D9A82E94F065Q27006982-87286E80-48CF-433A-A218-D5BC33760EF3Q27690671-BBA83B20-7287-43EE-ABB3-54C7101AD4C4Q27696195-71AB655A-C656-4497-A806-058B0676F730Q28287583-8A5EB662-016E-475F-BDA4-36000AACC88AQ30427768-3BE24BA7-9853-4533-A55E-152FF80BF894Q30496567-3DCF6E49-5164-4660-AE14-2C033232A31CQ30544585-BBE833BD-EDAA-462B-95EA-CF622F3EC1D6Q33402474-43D4CA69-B881-4A31-8330-E4E233BEA07FQ33665446-4804C116-5C26-4940-A4D8-F7C0A3C018BAQ33680317-4B0C5B9E-E1D8-4BE4-9E6C-191D8979477FQ33752486-FB9E8661-6887-4378-AA5F-F44AD443A345Q33980120-CB2B2E0C-5424-4753-B2C8-BF658928750EQ34136231-C3E3886B-501A-4D7A-8387-C97566A29DF9Q34138923-35686ADE-F8AA-4F2B-94AD-1CF1BC271E6BQ34975134-29FEF944-C719-48FA-AE68-5EAED89903E2Q35008824-71D8CA90-5C9E-4E48-A62D-1DACC93BF083Q35112654-53306E1E-82F3-45F7-8168-E47DCA984C44Q35931588-6109464B-3C9F-47B4-94B7-F3C3160C93F1Q35950501-CC8CE921-AEFF-422C-A35F-2FCE7302910DQ36411897-0DCF3181-AFD3-4CF0-B43E-870D3D84FCD7Q36459901-E75C16EF-952E-4014-BA98-E495CB54327FQ36548456-58FF32D0-8F38-41BB-A21C-A1C83007D21CQ36723137-9A420641-2F1E-4F74-A7CD-8C3A76C4F07AQ36851932-EDF2760C-B718-4C8D-8918-78247C8C744FQ37002968-F97962AD-CF6A-44E8-A39C-F032754248F3Q37123887-954F93B8-1691-4DFA-BAD5-F421DC03A202Q37162996-FF6C8A03-6149-436B-A950-94E2B8D4AC1AQ37163036-21E532EB-3697-4846-A3F3-0EE994E56A76Q37173205-D9B51D00-7D16-4D39-9EFB-4463D0546AAEQ37289377-35FC4F98-8C20-4BE0-A05C-82BC800A6D14
P2860
Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human high density lipoprotein ...... onent innate immune complexes.
@ast
Human high density lipoprotein ...... onent innate immune complexes.
@en
type
label
Human high density lipoprotein ...... onent innate immune complexes.
@ast
Human high density lipoprotein ...... onent innate immune complexes.
@en
prefLabel
Human high density lipoprotein ...... onent innate immune complexes.
@ast
Human high density lipoprotein ...... onent innate immune complexes.
@en
P2093
P2860
P356
P1476
Human high density lipoprotein ...... onent innate immune complexes.
@en
P2093
Amit Pahwa
April M Shiflett
Joseph R Bishop
Stephen L Hajduk
P2860
P304
32578-32585
P356
10.1074/JBC.M503510200
P407
P577
2005-07-26T00:00:00Z